Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.

Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Berchuck A, Cramer DW, Bandera EV, Wentzensen N, Kotsopoulos J, Narod SA, Phelan CM, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Terry KL; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):174-182. doi: 10.1158/1055-9965.EPI-17-0655. Epub 2017 Nov 15.

2.

Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

Harris HR, Titus LJ, Cramer DW, Terry KL.

Int J Cancer. 2017 Jan 15;140(2):285-291. doi: 10.1002/ijc.30441. Epub 2016 Oct 6.

4.

Women with polycystic ovary syndrome gain regular menstrual cycles when ageing.

Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J.

Hum Reprod. 2000 Jan;15(1):24-8.

PMID:
10611183
5.

Clinical implications of menstrual cycle length in oligomenorrhoeic young women.

Oh JY, Sung YA, Lee HJ.

Clin Endocrinol (Oxf). 2014 Jan;80(1):115-21. doi: 10.1111/cen.12243. Epub 2013 Jun 6.

PMID:
23663009
6.

Ovarian surgery for symptom relief in women with polycystic ovary syndrome.

Lepine S, Jo J, Metwally M, Cheong YC.

Cochrane Database Syst Rev. 2017 Nov 10;11:CD009526. doi: 10.1002/14651858.CD009526.pub2. Review.

PMID:
29125183
7.

A genetic risk score is associated with polycystic ovary syndrome-related traits.

Lee H, Oh JY, Sung YA, Chung HW.

Hum Reprod. 2016 Jan;31(1):209-15. doi: 10.1093/humrep/dev282. Epub 2015 Nov 15.

PMID:
26573528
8.
9.

Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome.

Glueck CJ, Woo JG, Khoury PR, Morrison JA, Daniels SR, Wang P.

Metabolism. 2015 Apr;64(4):539-53. doi: 10.1016/j.metabol.2015.01.005. Epub 2015 Jan 10.

PMID:
25633270
10.

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.

Hum Reprod. 2014 Oct 10;29(10):2339-51. doi: 10.1093/humrep/deu200. Epub 2014 Aug 1.

11.

Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women.

Jukic AMZ, Upson K, Harmon QE, Baird DD.

Fertil Steril. 2016 Jul;106(1):172-179.e2. doi: 10.1016/j.fertnstert.2016.03.004. Epub 2016 Mar 18.

12.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES).

Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.

PMID:
26509855
13.

Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Barry JA, Azizia MM, Hardiman PJ.

Hum Reprod Update. 2014 Sep-Oct;20(5):748-58. doi: 10.1093/humupd/dmu012. Epub 2014 Mar 30. Review.

14.

Epithelial ovarian cancer risk among women with polycystic ovary syndrome.

Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C.

Obstet Gynecol. 1996 Oct;88(4 Pt 1):554-9.

PMID:
8841217
15.

Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.

Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Brian Szender J, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, Cramer D, Doherty JA, Edwards RP, Fridley BL, Goode EL, Goodman MT, Hogdall E, Hosono S, Jensen A, Jordan S; Australian Ovarian Cancer Study Group, Kjaer SK, Matsuo K, Ness RB, Olsen CM, Olson SH, Leigh Pearce C, Pike MC, Anne Rossing M, Szamreta EA, Thompson PJ, Tseng CC, Vierkant RA, Webb PM, Wentzensen N, Wicklund KG, Winham SJ, Wu AH, Modugno F, Schildkraut JM, Terry KL, Kelemen LE, Moysich KB.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1114-24. doi: 10.1158/1055-9965.EPI-15-1330. Epub 2016 May 6. Review.

16.

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A; Ovarian Cancer Association Consortium.

Cancer Causes Control. 2013 May;24(5):989-1004. doi: 10.1007/s10552-013-0174-4. Epub 2013 Mar 2.

17.

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

Panidis D, Tziomalos K, Chatzis P, Papadakis E, Delkos D, Tsourdi EA, Kandaraki EA, Katsikis I.

Eur J Endocrinol. 2013 Jan 17;168(2):145-52. doi: 10.1530/EJE-12-0655. Print 2013 Feb.

PMID:
23109645
18.

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.

Risch HA, Marrett LD, Jain M, Howe GR.

Am J Epidemiol. 1996 Aug 15;144(4):363-72.

PMID:
8712193
19.

Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

Alebić MŠ, Stojanović N, Baldani DP, Duvnjak LS.

Endocrine. 2016 Dec;54(3):798-807. doi: 10.1007/s12020-016-1062-y. Epub 2016 Aug 3.

PMID:
27484772
20.

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS; Ovarian Cancer Association Consortium.

Int J Epidemiol. 2013 Apr;42(2):579-89. doi: 10.1093/ije/dyt042.

Supplemental Content

Support Center